-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Molecular Monitoring in Chronic Myeloid Leukemia and the Prospects for Treatment-Free Remissions

Program: Education Program
Session: Managing Typical and Atypical Chronic Myeloid Leukemia
Saturday, December 5, 2015, 9:30 AM-11:00 AM
Valencia BC (W415BC), Level 4 (Orange County Convention Center)
Sunday, December 6, 2015, 7:30 AM-9:00 AM
W224, Level 2 (Orange County Convention Center)

Michael W.N. Deininger, MD, PhD

University of Utah, Salt Lake City, UT

Disclosures: Deininger: Gilead: Research Funding ; Incyte: Consultancy , Other: Paid Advisory Board ; Celgene: Research Funding ; Novartis: Consultancy , Other: Paid Advisory Board , Research Funding ; Ariad: Consultancy , Other: Paid Advisory Board ; Bristol Myers Squibb: Consultancy , Other: Paid Advisory Board , Research Funding ; Pfizer: Consultancy , Other: Paid Advisory Board .

See more of: Managing Typical and Atypical Chronic Myeloid Leukemia
See more of: Education Program
<< Previous Presentation | Next Presentation >>